Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris;...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Jeldes, Hector Felipe, Mitchell, Robyn, McGeer, Allison, Rudnick, Wallis, Amaratunga, Kanchana, Vallabhaneni, Snigdha, Lockhart, Shawn R., Bharat, Amrita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288437/
https://www.ncbi.nlm.nih.gov/pubmed/32522237
http://dx.doi.org/10.1186/s13756-020-00752-3
_version_ 1783545276218212352
author Garcia-Jeldes, Hector Felipe
Mitchell, Robyn
McGeer, Allison
Rudnick, Wallis
Amaratunga, Kanchana
Vallabhaneni, Snigdha
Lockhart, Shawn R.
Bharat, Amrita
author_facet Garcia-Jeldes, Hector Felipe
Mitchell, Robyn
McGeer, Allison
Rudnick, Wallis
Amaratunga, Kanchana
Vallabhaneni, Snigdha
Lockhart, Shawn R.
Bharat, Amrita
author_sort Garcia-Jeldes, Hector Felipe
collection PubMed
description To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.
format Online
Article
Text
id pubmed-7288437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72884372020-06-11 Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018 Garcia-Jeldes, Hector Felipe Mitchell, Robyn McGeer, Allison Rudnick, Wallis Amaratunga, Kanchana Vallabhaneni, Snigdha Lockhart, Shawn R. Bharat, Amrita Antimicrob Resist Infect Control Short Report To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%. BioMed Central 2020-06-10 /pmc/articles/PMC7288437/ /pubmed/32522237 http://dx.doi.org/10.1186/s13756-020-00752-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Garcia-Jeldes, Hector Felipe
Mitchell, Robyn
McGeer, Allison
Rudnick, Wallis
Amaratunga, Kanchana
Vallabhaneni, Snigdha
Lockhart, Shawn R.
Bharat, Amrita
Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
title Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
title_full Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
title_fullStr Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
title_full_unstemmed Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
title_short Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
title_sort prevalence of candida auris in canadian acute care hospitals among at-risk patients, 2018
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288437/
https://www.ncbi.nlm.nih.gov/pubmed/32522237
http://dx.doi.org/10.1186/s13756-020-00752-3
work_keys_str_mv AT garciajeldeshectorfelipe prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT mitchellrobyn prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT mcgeerallison prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT rudnickwallis prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT amaratungakanchana prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT vallabhanenisnigdha prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT lockhartshawnr prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018
AT bharatamrita prevalenceofcandidaaurisincanadianacutecarehospitalsamongatriskpatients2018

Ejemplares similares